|
|
|
|
|
|
|
|
|
|
 
|
Pancreas Cancer
News and Archives |
|
Lanreotide Autogel Every 6
Weeks Compared with Lanreotide Microparticles Every 3 Weeks in
Patients with Well Differentiated Neuroendocrine Tumors: A Phase
III Study Cancer. 2006 Nov 15;107(10):2474-81.
PMID: 17054107 |
|
 |
|
|
For educational
purposes only; not to be relied upon Please read Pancreatica Disclaimer |
|
 Home | In The News | Links | Donations FAQ | Clinical Trials Database | Research Resources | About Us |
|
|
|
|
|
www.pancreatica.org |